Tvardi Therapeutics, Inc.
TVRD
Nasdaq
Manufacturing
Chemicals
$2.92
▼
$0.14
(-4.43%)
Cap. Mercado: 27.35 M
Precio
$2.92
Cap. Mercado
27.35 M
Rango del Día
$2.86 — $3.08
Rango de 52 Semanas
$2.75 — $43.65
Volumen
25,192
Apertura $2.98
Promedio 50D / 200D
$3.73
21.79% below
Promedio 50D / 200D
$14.25
79.54% below
Historial de Precios
Tendencias Financieras
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 7.14 M | 20.97 M | 41.87 M | 23.03 M |
| Net Income | -18.21 M | -70.87 M | -118.51 M | -85.47 M | -88.44 M |
| EPS (Diluted) | -3.26 | -15.53 | -2.19 | -1.59 | -1.74 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -26.75 M | -58.38 M | -121.50 M | -87.54 M | -89.08 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 18.01 M | 32.81 M | 108.51 M | 91.88 M | 82.70 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 95,000.0 | 192,000.0 | 259,000.0 | 248,000.0 | 248,000.0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | -398,000.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32.07 M | 43.83 M | 125.84 M | 182.24 M | 247.06 M |
| Total Liabilities | 11.13 M | 48.42 M | 68.76 M | — | — |
| Shareholders' Equity | 20.95 M | -4.59 M | 57.09 M | 158.78 M | 227.52 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 20.73 M | 37.90 M | 51.78 M | 63.74 M | 13.45 M |
| Current Assets | 31.54 M | 43.83 M | 116.16 M | 168.91 M | 173.29 M |
| Current Liabilities | 11.04 M | 3.97 M | 25.59 M | 23.46 M | 17.62 M |
{"event":"ticker_viewed","properties":{"ticker":"TVRD","listing_kind":"stock","pathname":"/stocks/tvrd","exchange":"Nasdaq","country":"US"}}